RecruitingNot ApplicableNCT07317219

Ayahuasca, Esketamine and Body Image Perception

Effects of a Single Dose of Ayahuasca or Esketamine on Body Image Perception in Women: a Randomized, Double-blind Study


Sponsor

University of Sao Paulo

Enrollment

20 participants

Start Date

Dec 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine on women body perception.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ayahuasca and a drug called Esketamine for people with healthy women volunteers. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAyahuasca

oral ayahuasca

DRUGEsketamine

oral esketamine


Locations(1)

Hospital das Clínicas da FMRP-USP

Ribeirão Preto, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07317219


Related Trials